VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 87 filers reported holding VAXCYTE INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,827,102 | -69.7% | 36,268 | -69.9% | 0.00% | -66.7% |
| Q2 2023 | $6,022,764 | +280.6% | 120,600 | +185.7% | 0.01% | +350.0% |
| Q1 2023 | $1,582,293 | -20.2% | 42,217 | +2.1% | 0.00% | -33.3% |
| Q4 2022 | $1,983,404 | +471.6% | 41,364 | +186.6% | 0.00% | +200.0% |
| Q3 2022 | $347,000 | +12.7% | 14,431 | +1.9% | 0.00% | – |
| Q2 2022 | $308,000 | +30.5% | 14,166 | +42.8% | 0.00% | – |
| Q4 2021 | $236,000 | – | 9,920 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 4,168,718 | $110,721,000 | 37.88% |
| Medicxi Ventures Management (Jersey) Ltd | 1,887,478 | $50,150,000 | 29.14% |
| Pivotal bioVenture Partners Investment Advisor LLC | 2,222,970 | $59,064,000 | 19.47% |
| FRAZIER MANAGEMENT LLC | 2,309,554 | $61,365,000 | 4.73% |
| TPG Group Holdings (SBS) Advisors, Inc. | 4,941,213 | $131,288,000 | 1.46% |
| RA Capital Management | 3,710,699 | $98,593,000 | 1.38% |
| Foresite Capital Management IV, LLC | 465,821 | $12,377,000 | 1.34% |
| Opaleye Management Inc. | 335,200 | $8,906,000 | 1.16% |
| Novo Holdings A/S | 416,937 | $11,078,000 | 0.48% |
| Affinity Asset Advisors, LLC | 30,000 | $797,000 | 0.42% |